Sensible Healthcare Systems is a healthcare startup focused on providing innovative biosensing solutions, particularly for glucose monitoring in individuals with (pre-)diabetes. Their flagship product, idi, utilizes painless microneedle technology to deliver glucose measurements through an inconspicuous device that connects effortlessly to the user’s lifestyle. idi's in-body sensing component is significantly smaller than current market sensors and can securely transmit data to various reading devices without the need for scanning or wires. The device is also designed to be reusable, with only the microneedle patch needing to be replaced weekly, allowing for a cost-effective solution in glucose control and management. The company aims to make biosensing technologies accessible to everyone.